Shenzhen Xinyang Weikang Technology

Shenzhen Xinyang Weikang Technology (Nycrist) is a specialized CRO and CDMO focused on solid-state technology and high-end pharmaceutical formulation development. Established in 2015 and based in Shenzhen, China, the company offers a comprehensive suite of services including crystal form screening, salt selection, co-crystal development, and GMP-compliant manufacturing. Nycrist operates an integrated platform for the production of advanced dosage forms such as oral films, topical formulations, and complex solid dosages. By leveraging its expertise in crystallization and solid-state characterization, the company helps pharmaceutical partners improve drug solubility, stability, and bioavailability. Nycrist maintains a strong international scientific advisory board and serves a global client base from its state-of-the-art 6,000-square-meter facility.